The National Institute of Standards and Technology (NIST) has issued its first-ever reference material designed to improve the performance and reliability of experiments to measure the masses and concentrations of peptides in biomolecular samples. The new reference material is expected to be an important tool in the analysis of proteins, both for disease diagnosis and drug discovery.
Proteomics—the study of proteins and the roles they play in biology—is one of the most fertile fields of modern medical research. Proteins typically are very large molecules, built of hundreds or thousands of amino acids, but they can be divided into smaller units, chains of about 50 or fewer amino acids. These are peptides. The usual way to analyze proteins is to chop them into their constituent peptides (generally with enzymes that cut through them at specific sites), sort the various peptides out using a chemical separation technique like high performance liquid chromatography (HPLC), and then determine the mass of each peptide using mass spectroscopy.
One big uncertainty in this process is that the peptide fragments differ in size, electrical charge and physical properties (such as the speed in which they separate under HPLC.) Chemists are accustomed to using well-known reference samples as chemical rulers to calibrate their analysis instrumentation, but until now there have been no such reference samples of peptides.
The need for this peptide reference material has been long recognized by the Association of Biomolecular Resource Facilities (ABRF), a non-profit standards organization created by representatives from industry firms, universities and government agencies. In collaboration with NIST, the ABRF created a Peptide Standards Project Committee to design and characterize three synthetic peptides to serve as the basis for a NIST peptide reference material. NIST RM 8327, "Peptide Reference Material for Molecular Mass and Purity Measurements," consists of three peptides from 11, 14 and 26 amino acid residues in length, with net charges of -3, -1 and +3. These three synthetic peptides were designed to provide long-term stability (do not contain methionine, cysteine and tryptophan), a range of purities, a range of molecular masses, protease cleavage sites, and contain tyrosine to enable concentration analysis by UV spectroscopy.
Source: National Institute of Standards and Technology (NIST)
Related stories:
Chemists make beds with soft landings
Bedsprings aren't often found in biology. Now, chemists have succeeded in making a layer of tiny protein coils attached to a surface, much like miniature bedsprings in a frame. This thin film made of stable and very pure helices can help researchers develop molecular electronics or solar cells, or to divine the biology of proteins.
Scientists identify 'missing link' in process leading to Alzheimer's disease
Scientists at the University of Virginia have identified what appears to be a major missing link in the process that destroys nerve cells in Alzheimer's disease, an incurable disease that slowly destroys memory and cognitive abilities. The findings are reported in the Nov. 20, 2006, issue of the
Journal of Cell Biology and could eventually lead to new drugs that target and disrupt specific proteins that conspire in the brain to cause Alzheimer's.
Nanoparticles Make Cancer Cells Visible
Wouldn’t it be nice if we could detect tumors and their metastases as easily as we find broken bones with X-rays? A team of scientists headed by S. Bhatia in Boston has been working on this problem. They have found a way to make a tumor-specific protease visible by using Fe
3O
4 nanoparticles and magnetic resonance imaging (MRI).
Study of ancient and modern plagues finds common features
In 430 B.C., a new and deadly disease—its cause remains a mystery—swept into Athens. The walled Greek city-state was teeming with citizens, soldiers and refugees of the war then raging between Athens and Sparta. As streets filled with corpses, social order broke down. Over the next three years, the illness returned twice and Athens lost a third of its population. It lost the war too. The Plague of Athens marked the beginning of the end of the Golden Age of Greece.
Children of centenarians live longer, have lower risk of heart disease, stroke, diabetes
A recent study appearing in the November issue of
Journal of American Geriatrics Society revealed that centenarian offspring (children of parents who lived to be at least 97 years old) retain important cardiovascular advantages from their parents compared to a similarly-aged cohort. The study is the first to assess the health of centenarian offspring over time and could be important for future research, as the subjects may be used as a model of healthy aging.
Landmark study defines benefits of early HIV testing and treatment for infected infants
Testing very young babies for HIV and giving antiretroviral therapy (ART) immediately to those found infected with the virus dramatically prevents illness and death, according to a report in the
New England Journal of Medicine. The study found that giving ART to HIV-infected infants beginning at an average age of 7 weeks made them four times less likely to die in the next 48 weeks, compared with postponing ART until signs of illness or a weakened immune system appeared--the standard of care when the study began.
Angular observation of joints of geckos moving on horizontal and vertical surfaces
New research shows that gecko's joints rotated more quickly the greater the speed, and the swinging scope of forelimbs stayed nearly at 59 degrees when swinging forward. The lifting angle of forelimbs was always positive to keep the center of mass close to the surface when moving up vertical surfaces. Alternative gaits had little effect on the swing angle of hind limbs of the geckos moving on both horizontal and vertical surfaces.
Could genetic research awaken racist attitudes?
People are different, both physically and mentally, but genetically everyone is very similar. That's been the thought of scientists for decades now. But with population research becoming more and more common, the University of Alberta's Tim Caulfield is concerned that genetic research could awaken racist attitudes.